Risk of neural tube defects higher for babies of women on HIV therapy with dolutegravir

Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other antiretroviral drugs.

from Sexual Health News -- ScienceDaily https://ift.tt/2Z6HHfV
via IFTTT